Serological Correlate of Protection in Guinea Pigs for a Recombinant Protective Antigen Anthrax Vaccine Produced from Bacillus brevis

OBJECTIVE: Recombinant protective antigen (rPA) is the active pharmaceutical ingredient of a second generation anthrax vaccine undergoing clinical trials both in Korea and the USA. By using the rPA produced from Bacillus brevis pNU212 expression system, correlations of serological immune response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chun, Jeong-Hoon, Choi, On-Jee, Cho, Min-Hee, Hong, Kee-Jong, Seong, Won Keun, Oh, Hee-Bok, Rhie, Gi-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korea Centers for Disease Control and Prevention 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738701/
https://www.ncbi.nlm.nih.gov/pubmed/24159510
http://dx.doi.org/10.1016/j.phrp.2012.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738701/
https://www.ncbi.nlm.nih.gov/pubmed/24159510
http://dx.doi.org/10.1016/j.phrp.2012.07.006

Ejemplares similares